CVS - CVS Health Corporation
| Previous Close | 73.35 |
| Open | 73.63 |
| Bid | 74.35 x 900 |
| Ask | 74.37 x 800 |
| Day's Range | 73.39 - 74.53 |
| 52 Week Range | 51.72 - 77.03 |
| Volume | 3634652 |
| Avg. Volume | 6,855,575 |
| Market Cap | 97B |
| Beta (3Y Monthly) | 0.88 |
| PE Ratio (TTM) | 20.99 |
| EPS (TTM) | 3.55 |
| Earnings Date | Feb 18, 2020 - Feb 24, 2020 |
| Forward Dividend & Yield | 2.00 (2.73%) |
| Ex-Dividend Date | 2019-10-23 |
| 1y Target Est | 79.74 |
- Yahoo Finance
Target CEO: We are taking 'enormous' market share in cosmetics
Target CEO Brian Cornell talks with Yahoo Finance about the company's success down the cosmetics aisle.
- Reuters
UPDATE 1-CVS to increase genetic testing for some cancer patients
CVS Health Corp said on Thursday it will make it easier for patients with advanced cancer enrolled in some Aetna insurance plans to receive broad genetic gene sequencing tests that can help identify the best drug or treatment for them. CVS has been running an oncology program in 12 states in which patients prescribed treatment regimens that follow National Comprehensive Cancer Network guidelines automatically receive prior authorization approval, speeding the time to starting their treatment. It will now add easier access to broad-panel gene sequencing tests to that program for patients in its at-risk Aetna plans, Alan Lotvin, CVS' chief transformation officer, said in an interview.
- PR Newswire
CVS Health Announces $750K in New Funding for California Harm Reduction Coalition
As part of its commitment to building healthier communities, CVS Health (NYSE: CVS) today announced it will be providing $750,000 over the next three years to the national Harm Reduction Coalition to improve the health and wellness of California residents impacted by prescription opioid misuse and abuse.
- PR Newswire
CVS Health Launches Transform Oncology Care™ Program to Help Improve Patient Outcomes and Lower Overall Costs
CVS Health (NYSE: CVS) today announced Transform Oncology Care™, anchored on a first-of-its-kind precision medicine strategy for payors. The program uses genomic testing results at the point-of-prescribing to help patients start on the best treatment, faster and in addition, matches eligible patients to clinical trials. Transform Oncology Care also uses the Company's local footprint and unique assets to improve patient outcomes and lower overall costs at every point of the cancer care journey.
- GuruFocus.com
Sugi Is Thriving in a Growth Industry
The company continues to open new stores, the industry is growing and consolidation portends good things for the larger players Continue reading...
- Zacks
CVS Health Rides on Aetna Prospects, Strong Selling Season
CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.
- Zacks
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
- Zacks
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
- MarketWatch
California fines CVS pharmacy chain a record $3.6 million for failing to recycle
California is fining the nation’s largest pharmacy health care provider a record $3.6 million for failing to redeem deposits on bottles and cans at some of its locations, regulators said Monday.
- Moody's
Rite Aid Corporation -- Moody's upgrades Rite Aid's PDR to Caa1-PD/LD
Moody's Investors Service ("Moody's") today upgraded Rite Aid Corporation's ("Rite Aid") Probability of Default rating to Caa1-PD from Caa3-PD and appended the PDR with the "/LD" (limited default) designation. There is no change in the company's SGL-3 speculative grade liquidity rating.
- PR Newswire
CVS Health Completes Rollout of Time Delay Safes in All of Its West Virginia Pharmacies
CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 58 CVS Pharmacy locations in West Virginia, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.
- Simply Wall St.
Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...
- GuruFocus.com
4 Health Care Stocks Gurus Broadly Own
November jobs report shows strong growth in education and health services Continue reading...
- Zacks
Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Yahoo Finance
20 businesses that died in the 2010s
Yahoo Finance takes a look back at some of the biggest corporate busts of the last decade.
- Bloomberg
Elizabeth Warren Wants to Spoil the Megamerger Party
(Bloomberg Opinion) -- The merger floodgates broke open five years ago, and now U.S. Senator Elizabeth Warren wants to close the hatch. Her proposed bill to substantially restrict big corporate tie-ups is more a presidential campaign statement than viable legislation — and it certainly won’t score her any more points with the Wall Street crowd — but she is calling attention to the maniacal pace of dealmaking in corporate America and the need to modernize antitrust laws that have permitted some recent problematic transactions.More than $7 trillion of takeovers of U.S. companies have been announced since this day in 2014 — 52,694 companies to be exact.(1) That compares with just $4.4 trillion of deals in the previous five-year period. The transactions grew over time as balance sheets flush with cash and income statements desperate for growth created a perfect storm, which more often than not was stoked by pliable regulators. The Walt Disney Co. acquired 21st Century Fox Inc.; Charter Communications Inc. bought Time Warner Cable Inc.; CVS Health Corp. took over Aetna Inc.; Marriott International Inc. merged with Starwood Hotels & Resorts Worldwide Inc.; and T-Mobile US Inc. is trying to buy Sprint Corp. Those are just some of the more recognizable names. Warren, one of the top-polling candidates heading into the Democratic primaries, wants to ban deals in which one company has annual revenue of more than $40 billion, or both businesses generate more than $15 billion in sales, according to a draft of the bill reviewed by Bloomberg News. (A notable exception would be companies facing insolvency.) That could effectively prevent every top airline, insurer, manufacturer, oil producer, retailer, technology platform and other conglomerates — perhaps even Warren Buffett’s M&A vehicle, Berkshire Hathaway Inc. — from making any acquisitions. It would sound the M&A death knell. The idea, however, is unlikely to gain broad support among lawmakers.Even so, it’s hard not to notice the rising drumbeat of politicians concerned about overreach by corporate giants, particularly those in the tech field. Senator Amy Klobuchar, another Democratic presidential candidate, plans to introduce separate antitrust legislation soon, Bloomberg News reported, citing a person familiar with the matter. (Michael Bloomberg, the founder and majority owner of Bloomberg LP, the parent of Bloomberg News and Bloomberg Opinion, is also campaigning for president.)For the Trump administration’s part, the U.S. Justice Department is already investigating whether tech giants — namely Apple Inc., Amazon.com Inc., Facebook Inc. and Google — are using their unchecked power to engage in harmful business practices. But as I wrote in July, if regulators are so concerned about protecting consumers from tech overreach, their glowing endorsement of T-Mobile’s takeover of Sprint is a funny way of showing it; it will shrink the U.S. wireless market from four to three major carriers and remove a company that’s helped to keep customer prices in check.Antitrust regulation under President Donald Trump has at times created questionable optics. Makan Delrahim, the Justice Department’s top antitrust enforcer, seemed to switch his stance on AT&T Inc.’s takeover of Time Warner Inc. as Trump railed against the deal. Time Warner was the parent of CNN, which Trump views as his personal nemesis. (I’ve argued that whatever the case, scrutiny of the megamerger was warranted considering the broad market power it gave to AT&T as media companies without such scale struggle to compete.) By comparison, Disney and Fox, which was controlled by Trump pal Rupert Murdoch, closed their megadeal with few regulatory hiccups. Warren has criticized other giant deals, such as the merger of SunTrust Banks Inc. and BB&T Corp. and the combination of seed makers Bayer AG and Monsanto Co. Given that they aren’t household names, though, most Americans are unfazed by or unaware of such deals, even though they may feel the effects later. Her bill would direct the government to take into account not just whether a merger will lead to higher prices but also what the impact might be on workers, privacy and industry innovation. To justify the cost of buying another large company, dealmakers tend to come up with ambitious estimates of synergies, a euphemism for layoffs. It’s clear that the meaning of “harm” needs to be expanded in the antitrust sense, and laws need to take a more holistic view of the potential consequences of M&A as the lines between industries continue to blur. The Big Tech factor also needs to be weighed, as some deals are being done in part to respond to companies like Amazon that are spreading their tentacles into new areas. On Wednesday, TV-network operators CBS Corp. and Viacom Inc. completed their own merger, a bid to cut costs and create more scale to compete against a new roster of even more powerful media giants: Amazon, Apple, AT&T and Disney. Even then, ViacomCBS Inc., as the merged entity is now called, may not be big enough, and so it may be only a matter of time before it gets swallowed. Warren’s overly broad proposal likely isn’t the answer. But Democrats do seem ready to at least try to rein in a market that’s gotten out of hand. For dealmakers, this may be last call at the M&A party.(1) Data compiled by Bloomberg as of Thursday morning. Excludes terminated deals.To contact the author of this story: Tara Lachapelle at tlachapelle@bloomberg.netTo contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tara Lachapelle is a Bloomberg Opinion columnist covering the business of entertainment and telecommunications, as well as broader deals. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
- PR Newswire
Aetna Foundation Announces $1 Million in Grants to Boys & Girls Clubs in Providence and Hartford
As part of its commitment to building healthier communities, the Aetna Foundation today announced it will be donating a total of $1 million to the Boys & Girls Clubs of Providence and Hartford. Both locations will receive $500,000 over the next five years.
- PR Newswire
CVS Health Announces Successful First Year of Aetna Integration at One Year Anniversary
CVS Health Corporation (NYSE: CVS) today announced it has successfully completed the first year of combined operations following the acquisition of Aetna in late 2018. The combined company has met or exceeded its first-year integration goals while introducing new, consumer-focused offerings as a result of its unmatched capabilities. CVS Health remains on track to meet its most recent 2019 net synergy guidance and remains confident in its net synergy targets for 2020 and 2021.
- Zacks
Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.
- American City Business Journals
Billions of pain pills were supplied in North Carolina -- here's where they went
Between 2006 and 2012, the data shows more than 2.5 billion prescription pain pills were supplied to North Carolina.
- American City Business Journals
UPS promotes Marken CEO to lead new Healthcare and Life Sciences unit
UPS tapped a leader to oversee the company's new health-care unit that's aimed at pharmaceutical, biopharma and medical device companies.
- Zacks
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
- Zacks
CVS Health Set to Acquire Centene's IlliniCare Health Plan
CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.
- PR Newswire
CVS Health Encourages Families to Get Their Flu Shot During National Influenza Vaccination Week
Recent data from the Centers for Disease Control and Prevention (CDC) indicate that seasonal flu activity is increasing week over week, with cases reported in nearly all states.i As National Influenza Vaccination Week (Dec. 1-7) begins, CVS Health (NYSE: CVS) reminds customers that it is not too late to get a flu shot to protect themselves and their family members from the flu.
